Flamm RK - Search Results

1

Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.

Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK. Shortridge VD, et al. Among authors: flamm rk. Antimicrob Agents Chemother. 2002 Mar;46(3):783-6. doi: 10.1128/AAC.46.3.783-786.2002. Antimicrob Agents Chemother. 2002. PMID: 11850262 Free PMC article.

2

Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus.

Almer LS, Shortridge VD, Nilius AM, Beyer JM, Soni NB, Bui MH, Stone GG, Flamm RK. Almer LS, et al. Among authors: flamm rk. Diagn Microbiol Infect Dis. 2002 Jul;43(3):225-32. doi: 10.1016/s0732-8893(02)00394-2. Diagn Microbiol Infect Dis. 2002. PMID: 12106956

3

PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae.

Bui MH, Stone GG, Nilius AM, Almer L, Flamm RK. Bui MH, et al. Among authors: flamm rk. Antimicrob Agents Chemother. 2003 Apr;47(4):1456-9. doi: 10.1128/AAC.47.4.1456-1459.2003. Antimicrob Agents Chemother. 2003. PMID: 12654693 Free PMC article.

4

In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.

Nilius AM, Shen LL, Hensey-Rudloff D, Almer LS, Beyer JM, Balli DJ, Cai Y, Flamm RK. Nilius AM, et al. Among authors: flamm rk. Antimicrob Agents Chemother. 2003 Oct;47(10):3260-9. doi: 10.1128/AAC.47.10.3260-3269.2003. Antimicrob Agents Chemother. 2003. PMID: 14506039 Free PMC article.

5

Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.

Doktor SZ, Shortridge VD, Beyer JM, Flamm RK. Doktor SZ, et al. Among authors: flamm rk. Diagn Microbiol Infect Dis. 2004 May;49(1):47-52. doi: 10.1016/S0732-8893(03)00130-5. Diagn Microbiol Infect Dis. 2004. PMID: 15135500

6

In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms.

Almer LS, Hoffrage JB, Keller EL, Flamm RK, Shortridge VD. Almer LS, et al. Among authors: flamm rk. Antimicrob Agents Chemother. 2004 Jul;48(7):2771-7. doi: 10.1128/AAC.48.7.2771-2777.2004. Antimicrob Agents Chemother. 2004. PMID: 15215148 Free PMC article.

7

Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae.

Cao Z, Zhong P, Ruan X, Merta P, Capobianco JO, Flamm RK, Nilius AM. Cao Z, et al. Among authors: flamm rk. Int J Antimicrob Agents. 2004 Oct;24(4):362-8. doi: 10.1016/j.ijantimicag.2004.04.013. Int J Antimicrob Agents. 2004. PMID: 15380262

8

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.

Flamm RK, Vojtko C, Chu DT, Li Q, Beyer J, Hensey D, Ramer N, Clement JJ, Tanaka SK. Flamm RK, et al. Antimicrob Agents Chemother. 1995 Apr;39(4):964-70. doi: 10.1128/AAC.39.4.964. Antimicrob Agents Chemother. 1995. PMID: 7786004 Free PMC article.

9

Novel mechanism of macrolide resistance in Streptococcus pneumoniae.

Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK. Shortridge VD, et al. Among authors: flamm rk. Diagn Microbiol Infect Dis. 1996 Oct;26(2):73-8. doi: 10.1016/s0732-8893(96)00183-6. Diagn Microbiol Infect Dis. 1996. PMID: 8985659

10

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

Shortridge VD, Doern GV, Brueggemann AB, Beyer JM, Flamm RK. Shortridge VD, et al. Among authors: flamm rk. Clin Infect Dis. 1999 Nov;29(5):1186-8. doi: 10.1086/313452. Clin Infect Dis. 1999. PMID: 10524961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page